298 related articles for article (PubMed ID: 25645301)
1. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
Jalkanen J; Yegutkin GG; Hollmén M; Aalto K; Kiviniemi T; Salomaa V; Jalkanen S; Hakovirta H
Circ Res; 2015 Mar; 116(7):1206-15. PubMed ID: 25645301
[TBL] [Abstract][Full Text] [Related]
2. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
[TBL] [Abstract][Full Text] [Related]
3. Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.
Lunkes GI; Lunkes DS; Leal D; Araújo Mdo C; Corrêa M; Becker L; Rosa CS; Morsch VM; Schetinger MR
Diabetes Res Clin Pract; 2008 Sep; 81(3):351-7. PubMed ID: 18644642
[TBL] [Abstract][Full Text] [Related]
4. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
5. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG
Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases.
Zhong EH; Ledderose C; De Andrade Mello P; Enjyoji K; Lunderberg JM; Junger W; Robson SC
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C15-C29. PubMed ID: 33052071
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signaling: a potential therapeutic target for ischemic stroke.
Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW
Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cells cope with hypoxia-induced depletion of ATP via activation of cellular purine turnover and phosphotransfer networks.
Losenkova K; Zuccarini M; Helenius M; Jacquemet G; Gerasimovskaya E; Tallgren C; Jalkanen S; Yegutkin GG
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1804-1815. PubMed ID: 29514048
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities.
Yegutkin GG; Wieringa B; Robson SC; Jalkanen S
FASEB J; 2012 Sep; 26(9):3875-83. PubMed ID: 22637533
[TBL] [Abstract][Full Text] [Related]
10. Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation.
Díaz-García E; García-Tovar S; Alfaro E; Zamarrón E; Mangas A; Galera R; Ruíz-Hernández JJ; Solé-Violán J; Rodríguez-Gallego C; Van-Den-Rym A; Pérez-de-Diego R; Nanwani-Nanwani K; López-Collazo E; García-Rio F; Cubillos-Zapata C
Front Immunol; 2022; 13():847894. PubMed ID: 35173744
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.
Fausther M; Lecka J; Soliman E; Kauffenstein G; Pelletier J; Sheung N; Dranoff JA; Sévigny J
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(4):G447-59. PubMed ID: 22135310
[TBL] [Abstract][Full Text] [Related]
12. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization.
Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT
Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes.
Clifford EE; Martin KA; Dalal P; Thomas R; Dubyak GR
Am J Physiol; 1997 Sep; 273(3 Pt 1):C973-87. PubMed ID: 9316419
[TBL] [Abstract][Full Text] [Related]
14. Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage.
Zeiner J; Loukovaara S; Losenkova K; Zuccarini M; Korhonen AM; Lehti K; Kauppinen A; Kaarniranta K; Müller CE; Jalkanen S; Yegutkin GG
J Mol Med (Berl); 2019 Mar; 97(3):341-354. PubMed ID: 30617853
[TBL] [Abstract][Full Text] [Related]
15. Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice.
Mercier N; Kiviniemi TO; Saraste A; Miiluniemi M; Silvola J; Jalkanen S; Yegutkin GG
Am J Pathol; 2012 Jan; 180(1):419-28. PubMed ID: 22074736
[TBL] [Abstract][Full Text] [Related]
16. Subclinical peripheral arterial disease in rheumatoid arthritis.
Stamatelopoulos KS; Kitas GD; Papamichael CM; Kyrkou K; Zampeli E; Fragiadaki K; Panoulas VF; Mavrikakis M; Sfikakis PP
Atherosclerosis; 2010 Sep; 212(1):305-9. PubMed ID: 20553683
[TBL] [Abstract][Full Text] [Related]
17. Alteration of purinergic signaling in diabetes: Focus on vascular function.
Zhou R; Dang X; Sprague RS; Mustafa SJ; Zhou Z
J Mol Cell Cardiol; 2020 Mar; 140():1-9. PubMed ID: 32057736
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves.
Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CD73 in the development of lower limb atherosclerosis.
Jalkanen J; Hollmén M; Jalkanen S; Hakovirta H
Purinergic Signal; 2017 Mar; 13(1):127-134. PubMed ID: 27832456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
